Immuno-Biological Laboratories Co., Ltd.
4570.T · JPX
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Market Cap | ¥4,470,460 | ¥4,796,431 | ¥3,790,578 | ¥3,045,501 |
| - Cash | ¥825,731 | ¥734,136 | ¥614,164 | ¥508,350 |
| + Debt | ¥204,227 | ¥235,982 | ¥234,990 | ¥233,998 |
| Enterprise Value | ¥3,848,956 | ¥4,298,277 | ¥3,411,404 | ¥2,771,149 |
| Revenue | ¥969,533 | ¥816,701 | ¥794,621 | ¥647,576 |
| % Growth | 18.7% | 2.8% | 22.7% | – |
| Gross Profit | ¥628,343 | ¥517,293 | ¥526,713 | ¥376,698 |
| % Margin | 64.8% | 63.3% | 66.3% | 58.2% |
| EBITDA | ¥226,548 | ¥128,107 | -¥332,000 | -¥249,501 |
| % Margin | 23.4% | 15.7% | -41.8% | -38.5% |
| Net Income | ¥249,047 | ¥186,694 | -¥289,731 | -¥258,767 |
| % Margin | 25.7% | 22.9% | -36.5% | -40% |
| EPS Diluted | 26.74 | 20.05 | -31.11 | -27.78 |
| % Growth | 33.4% | 164.4% | -12% | – |
| Operating Cash Flow | ¥183,495 | ¥133,775 | ¥26,458 | -¥93,204 |
| Capital Expenditures | -¥59,660 | -¥18,660 | ¥0 | ¥0 |
| Free Cash Flow | ¥123,835 | ¥115,115 | ¥26,458 | -¥93,204 |